Institut Bergonié

🇫🇷France
Ownership
Private
Established
1923-01-01
Employees
-
Market Cap
-
Website
http://www.bergonie.org

Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.

First Posted Date
2013-06-17
Last Posted Date
2021-01-27
Lead Sponsor
Institut Bergonié
Target Recruit Count
25
Registration Number
NCT01878890
Locations
🇫🇷

Institut Bergonié, Bordeaux, France

Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR)

First Posted Date
2013-06-13
Last Posted Date
2021-08-11
Lead Sponsor
Institut Bergonié
Target Recruit Count
124
Registration Number
NCT01876901
Locations
🇫🇷

Centre Alexis Vautrin, Vandoeuvre Les Nancy, Lorraine, France

🇫🇷

CHU DE BORDEAUX - Hôpital Saint André, Bordeaux, Aquitaine, France

🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

and more 6 locations

PAZOPANIB Efficacy and Tolerance in Desmoids Tumors

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-06-12
Last Posted Date
2021-03-05
Lead Sponsor
Institut Bergonié
Target Recruit Count
72
Registration Number
NCT01876082
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

First Posted Date
2013-06-12
Last Posted Date
2021-01-25
Lead Sponsor
Institut Bergonié
Target Recruit Count
24
Registration Number
NCT01876043
Locations
🇫🇷

Institut Claudius Regaud, Toulouse, France

🇫🇷

Hôpital de la Timone, Marseille, France

🇫🇷

Centre Oscar Lambret, Lille, France

and more 3 locations

Erectile Rating During the Treatment of Rectal Cancers Localized

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2013-04-30
Last Posted Date
2016-03-04
Lead Sponsor
Institut Bergonié
Target Recruit Count
12
Registration Number
NCT01843218
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast

First Posted Date
2013-04-26
Last Posted Date
2016-08-25
Lead Sponsor
Institut Bergonié
Target Recruit Count
231
Registration Number
NCT01841749
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

Assessment of the Effectiveness of Local Ablathermy Radio Frequency Bronchial Tumors Primitive

First Posted Date
2013-04-26
Last Posted Date
2021-01-19
Lead Sponsor
Institut Bergonié
Target Recruit Count
42
Registration Number
NCT01841060
Locations
🇫🇷

Hôpital Cochin, Paris, France

🇫🇷

CHU de Bordeaux, Bordeaux, France

🇫🇷

Hôpital de Tenon, Paris, France

and more 6 locations

Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-04-26
Last Posted Date
2021-03-16
Lead Sponsor
Institut Bergonié
Target Recruit Count
48
Registration Number
NCT01841047
Locations
🇫🇷

Centre Paul Strauss, Strasbourg, Alsace, France

🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

🇫🇷

Institut Curie, Paris, Ile De France, France

and more 2 locations

Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-04-10
Last Posted Date
2021-05-06
Lead Sponsor
Institut Bergonié
Target Recruit Count
54
Registration Number
NCT01827943
Locations
🇫🇷

CHU de Bordeaux, Bordeaux, France

🇫🇷

Centre François Baclesse, Caen, France

🇫🇷

Centre Léon Bérard, Lyon, France

and more 6 locations

Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2013-04-10
Last Posted Date
2013-04-10
Lead Sponsor
Institut Bergonié
Target Recruit Count
1
Registration Number
NCT01827969
Locations
🇫🇷

Institut Bergonié, Bordeaux, Aquitaine, France

© Copyright 2024. All Rights Reserved by MedPath